As Trump’s rescheduling executive order dominated the cannabis industry’s attention over the holiday period, Germany’s controversial medical cannabis bill quietly entered its most critical phase.
Germany has taken a significant step towards fulfilling its ambitious plans to roll out an adult-use cannabis framework this week, after the draft bill was approved by the Bundesregierung (Federal Cabinet).
Germany’s highly anticipated draft law for ‘Pillar 1’ of its cannabis legalisation plans has been hammered by industry stakeholders and would-be associations.
FEARS that German health ministers may be dragging their feet on rolling out cannabis legislation were definitively quashed earlier this month, as the Government resorted to unconventional tactics to speed the process along.
HUNDREDS of companies are still being hounded through the German courts for alleged breaches of the country’s strict cannabis laws – despite the country signalling its intent to imminently introduce adult-use legislation.
Leading German Cannabis Lawyer Kai-Friedrich Niermann reflects on 2021 and looks ahead to the challenges and opportunities that lie ahead in 2022 BC: What are the main opportunities and challenges for the European cannabis industry in 2022 K-FN: The cannabis industry in Europe in its various sectors – medical, commercial hemp and CBD – has…
With Germany’s Government-in-waiting set to deliver adult-use cannabis, BusinessCann explores the delivery challenges and how the legislation may be shaped.
By German Cannabis Lawyer Kai-Friedrich Niermann and Burkhard Blienert, Political Advisor, former German MP and former drug policy spokesman of the SPD Bundestag’s group.
AFTER failing to persuade the Government to permit the sale of CBD flowers German company Hanf Farm is turning to the courts.
